Eritemas figurados
DOI:
https://doi.org/10.29176/2590843X.273Palabras clave:
eritema figurado, eritema anular centrífugo, eritema gyratum repens, eritema migrans, eritema necrolítico migratorioResumen
Son muchas las enfermedades de la piel que adoptan patrones clínicos diversos, como configuración anular, circular, policíclica y arqueada, entre otras. Muchas de estas lesiones se han agrupado precisamente por esta morfología dentro del grupo de los eritemas figurados; es importante, entonces, tenerlas presentes al momento de observar un patrón distintivo de distribución clínica, para hacer un diagnóstico y prescribir un tratamiento adecuado y oportuno; además, en algunos casos, se deben sospechar causas orgánicas de base que desencadenan este tipo de lesiones reactivas, algunas de las cuales pueden llegar a tener un mal pronóstico.
En este artículo se revisan los principales eritemas figurados, entre ellos, el eritema anular centrífugo, eritema migrans, eritema gyratum repens y eritema necrolítico migratorio.
Biografía del autor/a
Ana Paula Giraldo
Médica, Residente de Dermatología, Universidad CES, Medellín, Colombia
Andrea Arango
Dermatóloga, Universidad CES
Referencias bibliográficas
2. Martinón-Torres F. Eritema figurado “tipo profundo.”An Esp Pediatr. 2000;53:380–2.
3. Kaminsky A. Eritemas figurados. Actas Dermosifiliogr. 2009;100(2):88–109.
4. Bottoni U, Innocenzi D, Bonaccorsi P, Carlesimo M, Faina P, Richetta A, et al. Erythema annulare centrifugum: report of a case with neonatal onset. J Eur Acad Dermatol Veneorol. 2002;16(5):500–3.
5. Klaber R. Erythema Gyratum Perstans (Colcott Fox). Proc R Soc Med. 1942;36(2):45.
6. Ziemer M, Eisendle K, Zelger B. New concepts on erythema annulare centrifugum : a clinical reaction pattern that does not represent a specific clinicopathological entity. Br J Dermatol. 2009;160(1):119–26.
7. García M, Pujol R, Gimenez-Arnau A, Barranco C. Annually recurring erythema annulare centrifugum: a distinct entity? J Am Acad Dermatol. 2006;54(6):1091–5.
8. Darier J. De l’érythème annulaire centrifuge. Ann Dermatol Syphilogr. 1916;6:57.
9. Mahood JM. Erythema annulare centrifugum: a review of 24 cases with special reference to its association with underlying disease. Clin. Exp. Dermatol. 1983 Jul;8(4):383–7.
10. Enomoto H. Erythema annulare centrifugum as the presenting sign of breast carcinoma. Eur Acad Dermatol Venereol. 2009;23:317–68.
11. Chodkiewicz H, Cohen P. Paraneoplastic Erythema Annulare Centrifugum Eruption: PEACE. Am J Ciln Dermatol. 2012;13(4):239–46.
12. Reichel M, Wheeland R. Inflammatory carcinoma masquerading as erythema annulare centrifugum. Acta Derm Venereol. 1993;73(2):138–40.
13. Lee H, Chang S, Lee M, Choi J, Moon K, Koh J. Metastatic gastric carcinoma presenting as an erythema annulare centrifugum-like lesion. J Dermatol. 2008;35(3):186–7.
14. Helbing I, Walewska R, Dyer M, Bamford M, Harman K. Erythema annulare centrifugum associated with chronic lymphocytic leukaemia. Br J Dermatol. 2007;157(5):1044–5.
15. Yaniv R, Shpielberg O, Shpiro D, Feinstein A, Ben-Bassat I. Erythema annulare centrifugum as the presenting sign of Hodgkin’s disease. Int J Dermatol. 1993;32(1):59–61.
16. Furue M, Akasu R, Ohtake N, Tamaki K. Erythema annulare centrifugum induced by molluscum contagiosum. Br J Dermatol. 1993;129(5):646–7.
17. Borbujo J, de Miguel C, Lopez A, de Lucas R, Casado M. Erythema annulare centrifugum and Escherichia coli urinary infection. Lancet. 1996;347(9005):897–8.
18. Hammar H. Erythema annulare centrifugum coincident with Epstein–Barr virus infection in an infant. Acta Paediatr Scand. 1974;63(5):788–92.
19. Jillson O. Allergic confirmation that some cases of erythema annulare centrifugum are dermatophytides. AMA Arch Derm Syphilol. 1954;70(3):355–9.
20. Burkhart C. Erythema annulare centrifugum. A case due to tuberculosis. Int J Dermatol. 1982;21(9):538–9.
21. Hendricks A, Lu C, Elfenbein G, Hussain R. Erythema Annulare Centrifugum Associated With Ascariasis. Arch Dermatol. 1981;117(9):582–5.
22. Betlloch I, Amador C, Chiner E, Varona C, Carbonell C, Vilar A. Erythema annulare centrifugum in Q fever. Int J Dermatol. 1991;30(7):502.
23. Shelley W. Erythema annulare centrifugum due to candida albicans. Br J Dermatol. 1965;77:383–4.
24. Goette D, Beatrice E. Erythema annulare centrifugum caused by hydrochlorothiazide-induced interstitial nephritis. Int J Dermatol. 1988;27:129–30.
25. Hogan D, Blocka K. Erythema annulare centrifugum associated with piroxicam. J Am Acad Dermatol. 1985;13(5 pt 1):840–1.
26. Garcia-Doval I, Peteiro C, Toribio J. Amitriptyline-induced erythema annulare centrifugum. Cutis. 1999;63(1):35–6.
27. Tsuji T, Nishimura M, Kimura S. Erythema annulare centrifugum associated with gold sodium thiomalate therapy. J Am Acad Dermatol. 1992;27(2 pt2):284–7.
28. Hudson L. Erythema annulare centrifugum: an unusual case due to hydroxychloroquine sulfate. Cutis. 1985;36(2):129–30.
29. Ashurst P. Erythema annulare centrifugum due to hydroxychloroquine sulfate and chloroquine sulfate. Arch Dermatol. 1967;95(1):37–9.
30. Merrett A, Marks R, Dudley F. Cimetidine-induced erythema annulare centrifugum: no cross-sensitivity with ranitidine. Br Med J. 1981;283:698.
31. Carsuzaa F, Pierre C. ´Erythe`me annulaire centrifuge al’aldactone. Ann Dermatol Venereol. 1987;114:375–6.
32. Weyers W, Díaz C, Weyers I. Erythema Annulare Centrifugum Results of a Clinicopathologic Study of 73 Patients. Am J Dermatopathol. 2003;25(6):451–62.
33. Braunstein B. Erythema annulare centrifugum and Graves´ disease. Arch Dermatol. 1982;118(9):623.
34. Altomare G, Capella G, Frigerio E. Sarcoidosis presenting as erythema annulare centrifugum. Clin Exp Dermatol. 1995;20(6):502–3.
35. Dippel E, Orfanos C, Zouboulis C. Linear IgA dermatosis presenting with erythema annulare centrifugum lesions: report of three cases in adults. J Eur Acad Dermatol Veneorol. 2001;15(2):167–70.
36. Tsuji T, Kadoya A. Erythema annulare centrifugum associated with liver disease. Arch Dermatol. 1986;122(11):1239–40.
37. Thami G, Sachdeva A, Kaur S, Mohan H, Kanwar A. Erythema annulare centrifugum following pancreatico-biliary surgery. J Dermatol. 2002;29(6):347–9.
38. Ibrahim S, Pryor J, Tausk F. Stress-induced erythema annulare centrifugum. Dermatol Online J. 2009;15(4):15.
39. Choonhakarn C, Seramethakun P. Erythema annulare centrifugum associated with pregnancy. Acta Derm Venereol. 1998;78(3):237–8.
40. Dogan G. Pregnancy as a Possible Etioiogic Factor in Erythema Annulare Centrifugum. Am J Clin Dermatol. 2009;10(1):33–5.
41. Rosina P, D’Onghia F, Barba A. Erythema annulare centrifugum and pregnancy. Int J Dermatol. 2002;41(8):516–7.
42. Kuhn A, Richter-Hintz D, Oslislo C, Ruzicka T, Megahed M, Lehmann P. Lupus erythematosus tumidus. A neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol. 2000;136(8):1033–41.
43. Ruiz H, Sánchez J. Tumid lupus erythematosus. Am J Dermatopathol. 1999;21(4):356–60.
44. Gniadecki R. Calcipotriol for erythema annulare centrifugum. Br J Dermatol. 2002;146(2):317–9.
45. Rao N, Pariser R. Annular erythema responding to tacrolimus ointment. J Drugs Dermatol. 2003;2(4):421–4.
46. Minni J, Sarro R. A novel therapeutic approach to erythema annulare centrifugum. J Am Acad Dermatol. 2006;54(3 spt 2):134–5.
47. De La Torre-Lugo E, Sánchez J. Erythema gyratum repens. J Am Acad Dermatol. 2011;64(5):89–90.
48. Eubanks L, Mcburney E, Reed R. Erythema Gyratum Repens. Am J Med Sci. 2001;321(5):302–5.
49. Gammel J. Erythema gyratum repens; skin manifestations in patient with carcinoma of breast. AMA Arch Derm Syphilol. 1952;66(4):494–505.
50. Boyd A, Neldner K, Menter A. Erythema gyratum repens: a paraneoplastic eruption. J Am Acad Dermatol. 1992;26(5 pt 1):757–62.
51. Holt P, Davies M. Erythema gyratum repens—an immunologically mediated dermatosis? Br J Dermatol. 1977;96(4):343–7.
52. Caux F, Lebbe C, Thomine E, Benyahia B, Flageul B, Joly P, et al. Erythema Gyratum Repens. A Case Studied With Immunofluorescence, Immunoelectron Microscopy And Immunohistochemistry. Br J Dermatol. 1994;131(1):102–7.
53. Bryan M, Lienhart K, Smoller B, Johnson S. Erythema gyratum repens in a case of resolving psoriasis. J Drugs Dermatol. 2003;2(3):315–7.
54. Kawakami T, Saito R. Erythema Gyratum Repens Unassociated With Underlying Malignancy. J Dermatol. 1995;22(8):587–9.
55. Reynoso C, Balderrama C, Martinez E, Tinoco E, Rodriguez E. Bullous pemphigoid with figurate erythema. A case report. Rev Med Inst Mex Seguro Soc. 2008;46(4):427–30.
56. Dermitsu T, Sasaki K, Iida E, Azuma R, Umemoto N, Kakurai M, et al. Urticarial Vasculitis Presenting as Erythema Gyratum Repens-Like Eruption. J Eur Acad Dermatol Venereol. 2009;23(2):215–7.
57. Yebra I, Garcia B, Camacho F. Eritema gyratum repens de Gammel y enfermedad de Hodgkin. Med Cutan Ibero Lat Am. 1983;11(4):281–6.
58. Kreft B, Marsch W. Lupus erythematosus gyratus repens. Eur J Dermatol. 2007;17(1):79–82.
59. Harrison P. The annular erythemas. Int J Dermatol. 1979;18(4):282–90.
60. Appell M, Ward W, Tyring S. Erythema gyratum repens. A cutaneous marker of malignancy. Cancer. 1988;62(3):548–50.
61. Steere A, Bartenhagen N, Craft J, Hutchinson G, Newman J, Rahn D, et al. The early clinical manifestations of Lyme disease. Ann Intern Med. 1983;99:76–82.
62. Biesiada G, Czepiel J, Leśniak M, Garlicki A, Mach T. Lyme disease: review. Arch Med Sci. 2012;8(6):978–82.
63. Wright WF, Riedel DJ, Talwani R, GilliamBL. Diagnosis and Management of Lyme Disease. Am Fam Physician. American Family Physician; 2012;85(11):1086–93.
64. Müllegger R, Glatz M. Skin manifestations of lyme borreliosis: diagnosis and management. Am J Clin Dermatol. 2008;9(6):355–68.
65. Burgdorfer W, Barbour A, Hayes S, Benach J, Grunwaldt E, Davis J. Lyme disease-a tick-borne spirochetosis? Science (80-. ). 1982;216(4552):1317–9.
66. Asbrink E, Hovmark A. Early and late cutaneous manifestations in Ixodes-borne borreliosis. Ann NY Acad Sci. 1988;539:4–15.
67. Mullegger R, Mchugh G, Ruthazer R, Binder B, Kerl H, Steere A. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. J Invest Dermatol. 2000;115:1115–1123.
68. Schoen R. Better Laboratory Testing for Lyme Disease : No More Western Blot. Clin Infect Dis. 2013;57(3):341–3.
69. Adam D, Cohen P, Ghazarian D. Necrolytic Migratory Erythema:Case Report and Clinical Review. J Cutan Med Surg. 2003;7(4):333–8.
70. Mallinson C, Bloom S, Warin A, Salmon P, Cox B. A glucagonoma syndrome. Lancet. 1974;2(7871):1–5.
71. Van Beek A, de Haas E, van Vloten W, Lips C, Roijers J, Canninga-van Dijk M. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. Eur J Endocrinol. 2004;151(5):531–7.
72. Tierney E BJ. Etiology and Pathogenesis of Necrolytic Migratory Erythema: Review of the Literature. MedGenMed. 2004;6(3):1–13.
73. Grewal P, Salopek T. Is Necrolytic Migratory Erythema Due to Glucagonoma a Misnomer ? A More Apt Name Might Be Mucosal and Intertriginous Erosive Dermatitis. J Cutan Med Surg. 2012;16(2):76–82.
74. Binnick A, Spencer S, Dennison W, Horton E. Glucagonoma syndrome. Report of two cases and literature review. Arch Dermatol. 1977;113(6):749–54.
75. Mendoza-Guil F, Hernandez-Jurado I, Burkhardt P, Linares J, Naranjo R. [Necrolytic migratory erythema associated with glucagonoma]. Actas Dermosifiliogr. 2005;96(3):175–8.
76. Burton J. Zinc and essential fatty acid therapy for necrolytic migratory erythema. Arch Dermatol. 1993;129(2):246.
77. Blackford S, Wright S, Roberts D. Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acids. Br J Dermatol. 1991;125(5):460–46.
78. Smith A, Doolas A, Staren E. Rapid resolution of necrolytic migratory erythema after glucagonoma resection. J Surg Oncol. 1996;61(4):306–9.
Cómo citar
Descargas
Descargas
Publicado
Cómo citar
Número
Sección
Estadísticas de artículo | |
---|---|
Vistas de resúmenes | |
Vistas de PDF | |
Descargas de PDF | |
Vistas de HTML | |
Otras vistas |